Q2 2015 Interim Report PresentationCEO D. Ry Wagner

CFO John Janczak

August 6, 2015

2

Cautionary Statement on Forward-Looking Statements

Certain statements in this document constitute "forward-looking statements.'' All statements other than statements of historical facts

included in this document, including those regarding our future financial position and results, business strategy, plans and objectives of

management for future operations, including development plans and statements on industry growth are forward-looking statements.

These statements may be identified by words such as "expects," "looks forward to," "anticipates," "intends," "plans," "believes," "seeks,"

"estimates," "will," "project" or words of similar meaning.

Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results,

business strategy, performance or achievements, or industry results, to be materially different from any future results, performance or

achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous

assumptions regarding our present and future business strategies and the environment in which we will operate in the future. Factors

that could cause our actual results, performance or achievements to differ materially from those in the forward-looking statements

include, among others, changes in the political, economic or regulatory conditions in the markets in which we operate, and currency

exchange fluctuations.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future

results, levels of activity, performance or achievements.

• Q2 Sales Revenue at USD 1.3 million vs. USD 3.9 million in Q2 2014.

• Matthieu Baumgartner and Svetoslav Valkov appointed to the Board of Directors.

• Steve Sinkula, Vice President Business Development, and Dr. Michael Austin, Head of Global Agronomy, join Agrinos.

• HYT® B launched as a foliar nutrition product in the U.S., Brazil, and India.

• Milestones achieved for significantly increased yield and profitability for Umoe Bioenergy sugarcane operations in Brazil.

3

Highlights

4

Financial Review

• Q2 Recognized Sales Revenue at USD 1.3 million reflecting current business seasonality

• Total Operating Expense lower by 25% compared to Q2 2014

• EBITDA USD -4.1 vs -3.4 in Q2 2014

• Cash and Equivalents totaled USD 10.4 million

• Total number of employees increased from 141 to 147

5

Financial Summary Q2 2015

6

Q2 Sales Revenue

7

Profit and LossCondensed and Unaudited

USDl H1 2015 Q2 2015 Q1 2015 Year 2014

Sales revenue 2,507,509 1,334,192 1,173,316 6,276,419

Other operating revenue 15,471 9,708 5,763 875,118

Operating revenue 2,522,979 1,343,901 1,179,079 7,151,537

Cost of goods sold (802,595) (494,963) (307,632) (2,202,626)

Salaries and personnel costs (5,618,162) (2,397,750) (3,220,412) (11,644,854)

Depreciation and amortization (1,158,413) (586,829) (571,584) (2,625,793)

Other operating expenses (4,742,680) (2,501,455) (2,241,226) (25,730,731)

Earn-out - - - (179,687)

Total operating expenses (12,321,850) (5,980,996) (6,340,854) (42,383,691)

Operating income (9,798,871) (4,637,096) (5,161,776) (35,232,154)

Net financial income / expense (-) 1,643,112 930,042 713,070 7,589,290

Net income / loss (-) before taxes (8,155,760) (3,707,054) (4,448,706) (27,642,864)

Tax expense (88) (88) - (2,078,008)

Minority Interest. 99,820 45,748 54,072 206,995

Net income / loss (-) (8,056,027) (3,661,394) (4,394,634) (29,513,877)

• Q2 recognized sales revenue of USD 1.3m

a decrease of USD 2.6m to Q2 2014 and is

largely attibuted to the timing of the

Kingenta purchases and weather-related

sales impact in the U.S.

• Cost of goods sold of USD .49 m reflects

the sales volume

• Salaries and personnel costs lower in Q2

vs. Q1 by .82m. Primarliy driven by

redundancy costs concluded in Q1.

• Agrinos had 147 employees (FTE) at the

end of Q2 up from 141 at the end of Q1.

• EBITDA pre earn-out negative USD 4.1m

8

Balance Sheet – AssetsCondensed and Unaudited

USD 06.30.2015 03.31.2015 12.31.2014

Assets

Goodwill 3,918,513 4,174,267 6,059,319

Other intangible assets 1,954,568 1,945,745 1,450,687

Deferred Tax Asset 290,382 289,977 279,243

Total intangible assets 6,163,462 6,409,989 7,789,249

Land 63,816 65,147 67,968

Buildings 3,009,950 3,041,323 2,936,094

Improvements to leased premises 1,516,936 1,163,317 1,230,843

Vehicles 583,587 588,986 670,609

Machines, fixtures and fittings etc. 5,765,979 5,810,957 6,166,190

Accumulated depreciation (3,414,228) (3,150,273) (3,282,507)

Total tangible fixed assets 7,526,040 7,519,457 7,789,197

Investments in other shares and interests 2,316 2,556 -

Total non-current assets 13,691,819 13,932,002 15,578,446

Inventories 9,272,085 9,681,188 10,267,620

Accounts receivable 11,671,434 12,561,519 13,826,816

Other receivables 7,890,463 8,194,097 8,860,696

Total receivables 19,561,897 20,755,616 22,687,512

Bank deposits, cash etc. 10,396,094 14,176,038 20,569,843

Total current assets 39,230,075 44,612,842 53,524,975

Total assets 52,921,894 58,544,844 69,103,421

• Inventories down to USD 9.3 million

reflecting the sales for the first half of the

year.

• There has been no significant production

during the first half of the year.

• Accounts Receivable down by USD .89

million to USD 11.7 million due to stepped

up collection.

• Other receivables down USD .3 from Q1

driven by VAT collection in Mexico.

Included in this balance is USD 7.4m in VAT

the largest part is related to operations in

Mexcio.

9

Balance Sheet – Equity and LiabilitiesCondensed and Unaudited

USD 06.30.2015 03.31.2015 12.31.2014

Equity

Share capital 97,803 97,803 97,803

Premium reserve 131,176,300 131,176,300 131,176,300

Total paid in capital 131,274,103 131,274,103 131,274,103

Minority interests (566,827) (523,749) (624,390)

Accumulated P&L (117,982,816) (113,501,884) (105,056,004)

Total equity 13,291,287 17,772,219 26,218,099

Liabilities

Deferred tax - - -

Total provisions for liabilities - - -

Other non-current liabilities 15,140,527 15,064,550 15,613,433

Total non-current liabilities 15,140,527 15,064,550 15,613,433

Accounts payable 3,790,299 3,800,031 4,114,675

Current tax payable 226,286 231,383 1,154,020

Other current liabilities 21,040,322 22,200,409 22,627,584

Total current liabilities 25,056,908 26,231,823 27,896,279

Total liabilities 40,197,435 41,296,374 43,509,712

Total equity and liabilities 52,921,894 58,544,844 69,103,421

• Accounts Payable Flat to in Q2 vs. Q1.

• Other liabilities for the quarter was USD

21.0m. The main components are deferred

sales revenue, interest, and income

accures of USD 12.0m. In addition taxes

and VAT of USD 6.8m make up the

remainder.

10

Cash FlowCondensed and Unaudited

USD H1 2015 Q2 2015 Q1 2015 YE 2014

Cash flow from operating activities

Profit/Loss (-) before tax (8,155,760) (3,707,054) (4,448,706) (27,642,864)

Depreciation and amortization 1,158,413 586,829 571,584 2,625,793

Changes in inventories,receivables and payables 1,281,779 427,907 853,872 16,249,665

Changes in other accruals/currency effects (4,713,476) (816,957) (3,896,519) (11,340,568)

Net cash flow from operating activities (10,429,043) (3,509,275) (6,919,768) (20,107,974)

Cash flow from investment activities

Investments/disposals of tangible fixed assets 728,201 (346,659)

1,074,846 627,948

Changes in other investments - - - -

Net cash flow from investments activities 728,201 (346,659)

1,074,846 627,948

Cash flow from financing activities

Proceeds from borrowings( current and non-current) (472,906)

75,976 (548,883)

14,983,200

Net proceeds from issuance of shares (0)

-(0)

-

Net cash flow from financing activities (472,907)

75,976 (548,883)

14,983,200

Net change in cash and cash equivalents (10,173,749) (3,779,958) (6,393,805) (4,496,826)

Cash and cash equivalents at beginning of period 20,569,843 14,176,052 20,569,843 25,066,669

Cash and cash equivalents at end of period 10,396,094 10,396,094 14,176,038 20,569,843

• The net cash flow from operating

activities amounted to negative USD

3.5m in the quarter a significant

imporvement compared to Q1.

• The cash positon of USD 10.4m at

the end of the quarter.

11

Business Review

Agrinos growth strategy

12

Organization

Crops

Geography

Technology

In 2014, Agrinos defined a strategy to build the organizational capabilities and focus to

maximize the value of our competitive advantage and deliver long-term profitable growth.

Design and build an

organization that

enables rapid and

responsible growth in

multiple geographies

Prioritize R&D and

commercial efforts on

global crops that will

deliver the greatest

impact to our customers

and the company

Focus on countries and

regions positioned to

embrace our technology,

and where we can

exercise our competitive

advantages

Initiate significant

investments to enhance

our current technologies

and to set the stage for

the development of new

technologies

Strategic reorganization and investments

13

Q4-13

Q3-14

Q4-14

Q1-15

Q2-15

Q1-14

Q2-14

D. Ry Wagner appointed as CTO

D. Ry Wagner named CEO

Corporate Leadership, Commercial & Technical team structures defined

John Janczak joins as CFO

Global Biological Solutions R&D Center opens in Davis, CA

Global Biological Solutions R&D Center expansion to 19,000 square feet initiated

Steve Sinkula joins as VP of Global Business Development

Global strategy and reorganization launched

Established Global R&D strategy defined and team/laboratory build-out plan initiated

Manor Investments becomes a strategic investor

Global R&D Executive Leadership Team completed

Global Finance & Accounting Team established in Dallas, TX

Local production, worldwide distribution network

14

Product portfolio delivering must have attributes

15

Creates a highly productive

microbial system in the soil

Promotes absorption of nitrogen and

critical minerals to increase the level

of bioavailable nutrients to the crop

root system

A unique nutrient solution that

increases the activity of multiple

critical metabolic pathways in the

crop

Contains carbon, nitrogen, true

protein, amino acids, and essential

metabolic micronutrients

A fertility solution that increases crop

productivity and supports soil health

Contains organic, biologically-

extracted micronized chitin, amino

acids, and other crucial plant

nutrients

Stimulates root biomass formation

resulting in a more vigorous root

system

Enhances crop quality and fertility

under both favorable and stressful

growth conditions

Provides a source of time-released

nitrogen that is highly bioavailable

and complements applied nitrogen

Enhances crop tolerance to

environmental and physiological

stresses

Improves root structure to support

plant growth and productivity

Strengthens plant function to

increase tolerance to environmental

stresses

Enhances soil health to support

plant well-being

Benefits Benefits Benefits

16

Developing a world-class R&D

Located in a global center for the

development of Biological

Solutions: Davis, California

– Serves to attract and retain strong

talent to Agrinos

– Linkages to major agricultural and

biotech expertise and collaboration

opportunities with the University of

California, Davis

– Pilot fermentation capability,

microbiology, analytical

biochemistry, data analysis to

become an internal core

competency

R&D facility expanded to 19,000

sq. feet in 2015/2016

Global Biologicals Solutions Center

Highly supportive key market growth drivers and distribution partners

17

Key distribution partners

987

750

1 500

1 250

1 000

500

2 000

2 250

2 750

1 750

2 500

250

0

1 671

1 486

1 111

2015e2014

USDm

2019e

1 788

2 690

Source: Team Analysis, MicroMarket Monitor Bio-Fertilizer Market

Analysis, Biostimulant Coalition

Bio-Fertilizers

Bio-Stimulants

Biological input growth projection

Distribution Agreements Signed

2013 Security Seed & Chemical (U.S.)

DCM Shiram Consolidated (India)

2014

G.S. Long Co. (U.S.)

Helena Chemical Co. (U.S.)

Kingenta Ecological Engineering Group Co.,

Ltd. (China)

The Tremont Group (U.S.)

2015

Rallis (India)

Zuari Agri Sciences (India)

Crop Protection Services (U.S.)

Buttonwillow Warehouse Co. (U.S.)

18

Business ReviewSummary and Outlook

Outlook and Focus for FY 2015

• Focus on core business units to create strong revenue growth driven by

expansion of the distribution networks

• R&D organization to be expanded and Davis lab to be completed and fully

equipped in 2015

• Continue efforts to further strengthen the Board of Directors with focus on

expertise in agricultural technologies and markets

• Continue work on strategic partnership development throughout the year

• Initiate new production of some key products due to increased market

demand and decreasing inventory

19

Business ReviewSummary and Outlook

20

Business ReviewSummary and Outlook• Matthieu Baumgartner and Svetoslav Valkov appointed to the Board of

Directors.

• New distribution agreements signed with Rallis, in India, and ButtonWillow

Warehouse Company in the U.S. Western region.

• Three new patents applications Agrinot HYT® technology platform.

• HYT® B launched as a foliar nutrition product in the U.S. Brazil, and India.

• Milestones achieved for significantly increased yield and profitability for Umoe

Bioenergy sugarcane operations in Brazil.

• Steve Sinkula, Vice President Business Development, and Dr. Michael

Austin, Head of Global Agronomy, join Agrinos.